Alonso Krangle LLP Calls for Universal Screening of Newborns for Heart Birth Defects And Cardiac Birth Defects via Pulse Oximetry

Share Article

Newly-Published Lancet Study Indicates Pulse Oximetry Can Detect over Three Quarters of Heart Birth Defects and Cardiac Birth Defects in Newborn Infants

Alonso Krangle LLP - Fighting for victims of personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice negligence, qui tam/whistleblower actions and consumer fraud cases.

Alonso Krangle LLP - Fighting for victims of personal injury cases, defective drug and medical device litigation, construction accidents, nursing home abuse, medical malpractice, whistleblower

Alonso Krangle LLP represents victims of Heart Birth Defects and Cardiac Birth Defects caused by exposure to certain medications, including selective serotonin reuptake inhibitor (SSRI) antidepressants

Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, are today calling for the universal screening of newborn infants for Heart Birth Defects, Cardiac Birth Defects via a simple test called pulse oximetry. New research published this week in The Lancet indicates that use of pulse oximetry soon after birth could detect more than three quarters of all Heart Birth Defects, Cardiac Birth Defects in seemingly healthy babies, with few false positive results. [thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960107-X/fulltext]

Certain Heart Birth Defects and Cardiac Birth Defects may be caused by certain drugs. Alonso Krangle LLP represents victims of Heart Birth Defects and Cardiac Birth Defects caused by exposure to certain medications, including selective serotonin reuptake inhibitor (SSRI) antidepressants such as:

The firm is currently offering FREE lawsuit evaluations to any family who believes their child’s heart defect is related to their mother’s use of a SSRI antidepressant or another drug during pregnancy. To discuss a potential antidepressant birth defect lawsuit claim with one of the experienced and compassionate birth defect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

Heart Birth Defects, Cardiac Birth Defects And Pulse Oximetry Test
Heart Birth Defects, Cardiac Birth Defects are the leading cause of infant death. However, detecting these disorders early can greatly approve outcomes among afflicted babies. Pulse oximetry is an inexpensive, non-invasive test that involves measuring the extent to which red and infrared light is absorbed by a sensor attached to a patient’s body, usually on the finger or earlobe. The measurement indicates how well oxygenated the blood is. In a newborn, low oxygenation can indicate that a baby has a heart defect. [rcjournal.com/cpgs/pulsecpg.html]

According to The Lancet study, a meta-analysis of 13 studies involving 230,000 newborns, pulse oximetry showed an accuracy rate of 99.9 percent, and detected 76.5 percent of all congenital heart-defect cases and had a low false-positive rate of .14 percent. According to the study’s authors, the findings “provide compelling evidence for introduction of pulse oximetry as a screening method in clinical practice.”

According to Alonso Krangle LLP, early detection of Heart Birth Defects, Cardiac Birth Defects can greatly reduce infant mortality, as well the costs associated with emergency room visits and expensive surgical repairs. But so far, only four U.S. states – New Jersey, Indiana, Maryland and Virginia – have enacted laws requiring routine pulse oximetry screening for newborn infants. In light of The Lancet findings, Alonso Krangle LLP calls on all states to enact similar requirements as soon as practically possible. [abcnews.go.com/Health/universal-heart-screening-recommended-newborns/story?id=16252136#.T6FycFL4JqM]

Heart Birth Defects, Cardiac Birth Defects And SSRI Antidepressants

Since the first SSRI (Prozac) was approved by the U.S. Food & Drug Administration (FDA), the agency has issued several warnings about the drugs and birth defects. In 2005, the agency warned that studies have shown that infants born to women who had first trimester Paxil exposure had an increased risk of Heart Birth Defects, Cardiac Birth Defects, primarily ventricular and atrial septal defects (VSDs and ASDs). [fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108527.htm] In 2006, the FDA asked the manufacturers of several SSRI antidepressants to add information to their labels describing the potential risk of persistent pulmonary hypertension of the newborn (PPHN) after a study in the New England Journal of Medicine (NEJM) found a six-fold increased risk of the disorder among infants born to mothers who took an antidepressant in the last trimester of pregnancy. [fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150749.htm]

In 2007, another NEJM study found that babies born to women who used an SSRI antidepressant during the first trimester of pregnancy were twice as likely to suffer heart-related birth defects. The most common heart defects seen in that study were ventricular outflow defects and septal defects. [http://www.nejm.org/doi/full/10.1056/NEJMoa067407

Alonso Krangle LLP is currently investigating the association between the occurrence of Heart Birth Defects, Cardiac Birth Defects and SSRI antidepressants, including:

  • Ventral septal defect (VSD)
  • Atrial septal defects (ASD)
  • Tetralogy of Fallot
  • Hypoplastic left heart syndrome
  • Hypoplastic right heart syndrome
  • Coarctation of the aorta
  • Persistent Pulmonary Hypertension of Newborn (PPHN)

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

Alonso Krangle LLP offers a FREE lawsuit consultation to any family whose child may have suffered a Heart Birth Defect, Cardiac Birth Defect, as a result of an SSRI antidepressant or other medication. To discuss a antidepressant lawsuit with one of the experienced and compassionate birth defect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact: Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York
11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle

Andres Alonso
Visit website